Pluristyx Inc., the leader in advanced induced pluripotent stem cell (iPSC) technologies, announces today the Initial Close of their Series A financing led by a global Fortune 500 company along with ...

Proprietary Synthetic Polynucleotide Platform Accelerates Non-Viral, Footprint-Free Induced Pluripotent Stem Cell Generation Amid Surging Commercialization of iPSC Therapies in JapanSEATTLE, June 16, ...

Sparkling Sciences Co., Ltd., under TOMO YUME Group, announced it has obtained international INCI certification for iPSC Exosome and completed Kyoto University's patent licensing agreement. INCI Name: ...

Aging, at its most fundamental level, is a molecular process. Chemical marks on the genome shift and lose fidelity over time, ...

iPSC-based models of heart disease are furthest along. Development of treatments, by engineering sheets of heart cells or directly reprogramming other heart cells, is still in the preclinical or very ...

Ancient genes from single-celled organisms have been used to reprogram mouse cells and influence embryonic development, ...

Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before. Earlier this week, Life Biosciences, a biotech company focused on reversing age-related ...

Biomedical engineers use iPSCs to grow specialized retinal endothelial cells, successfully regenerating damaged eye blood ...

Plus: SpaceX has officially delivered the largest IPO in history. This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the world of ...

Test time has arrived: the first person has been treated in a highly anticipated gene-therapy trial that aims to coax aged cells to take on a younger identity. The clinical trial is testing an ...

There has been growing recognition that gut health may play a role in Parkinson’s disease—a brain disorder. This article ...